Devices

Self-management of diabetes can be more successful when telemonitoring is included.

An interoperable artificial pancreas system smartphone app was designed, developed, and tested to make decision-making algorithms while running on an unlocked smartphone.  An Artificial Pancreas system closes the loop between a continuous glucose monitor (CGM) and an insulin pump by creating an algorithm that adjusts the insulin dose to control blood glucose …

Less than 20% of children with type 1 diabetes attain the target glycated hemoglobin level of less than 7% recommended by the American Diabetes Association.

The first study conducted on this device that explores the effectiveness and safety parameters. 

Patients are relieved to know that care continues through the coronavirus pandemic. 

Young children with type 1 diabetes often experience greater insulin variability, leading to more complications and a subpar quality of life.

Insulin delivery method or blood glucose monitoring – which is more important?

CGM use in young children with type 1 diabetes has its benefits and challenges, according to their parents.

Evidence suggests that pregnant women with type 1 diabetes can achieve optimal glucose control based on temporal glucose profiles.  

The do-it-yourself artificial pancreas systems (DIYAPS) offer a solution to patients who lack access to, or can’t afford, other technological options.